Table 5 Comparisons of Sulaimaniyah Kurdish breast cancer patients with Egyptian and with US white and African American women by age, hormone receptor (HR) and HER2 status, and age standardized and age specific incidence rates

Characteristics

No.

%

No.

%

No.

%

No.

%

Patients

265

203^a

967

814

Age Mean

48.7 ± 11.1

51.3 ± 10.8

61.2 ± 14.6

56.9 ± 13.4

<50

155

58.5

92/172

53.5

210

21.7

258

31.7

≥50

110

41.5

80/172

46.5

767

78.3

556

68.3

HR and HER2

ER+

194

73.2

132

65.0

732/903

81.1

506/773

65.5

PR+

170

64.2

89

43.8

636/901

70.6

426/771

55.3

HER2+

54

20.4

51

25.1

108/821

13.2

110/689

16.0

Triple subtypes

ER+/PR+/HER2-

145

54.7

-

-

605/814

74.3

394/687

57.4

ER+/PR+/HER2+

15

5.7

-

-

67/”

8.2

60/”

8.7

ER-/PR-/HER2+

29

10.9

-

-

41/”

5.0

49/”

7.1

ER-/PR-/HER-

33

12.4

23

11.3

101/”

12.4

184/”

26.8

Incidence ^b,c

Total

40.5

53.9 ^d

116.0

82.7

ER+/PR+/HER2-

<50

16.4

-

37.7

28.1

≥50

45.5

-

226.1

179.2

ER+/PR+/HER2+

<50

2.6

-

7.6

7.4

≥50

1.3

-

20.5

19.5

ER-/PR-/HER2+

<50

4.0

-

3.2

5.7

≥50

6.3

-

14.4

16.9

ER-/PR-/HER-

<50

3.8

-

8.7

15.7

≥50

10.0

-

36.4

69.0